azacitidine,venetoclax,pivekimab sunirine
abbvie,roche,immunogen
['aza ', 'aml,(-streamline),(-seamless),(-kamloops),(-latamleaders)', 'pivekimab', 'aml,(-streamline),(-seamless),(-kamloops),(-dreamlike)', 'imab ']
naval daver presents results from a phase 1b/2 on pivekimab sunirine, targeting cd123 combined with aza and ven in aml patients. #ash22 
The Lancet Haematology is a world-leading #haematology journal publishing peer-reviewed research and reviews, opinion, and news. #hematology